Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone and Metformin in Bangladeshi Type 2 Diabetic Subjects
NCT01589445Phase 4Completed
- Sponsor
- University of Dhaka
- Start
- Nov 2008
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, double-blind trial of pioglitazone in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by University of Dhaka. Primary endpoints: Fasting Serum Glucose at 3 months, Glycosylated Hemoglobin at 3 months and 5 more. Started Nov 2008; status: completed.
02
Drugs
pioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01589445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01589445.